Xact Kapitalforvaltning’s Ultragenyx Pharmaceutical RARE Stock Holding History

Xact Kapitalforvaltning’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$383K	Hold	8,623	–	–	0.01%	881
2019 Q4	$368K	Hold	8,623	–	–	0.01%	1146
2019 Q3	$369K	Hold	8,623	–	–	0.01%	1100
2019 Q2	$548K	Buy	8,623 +1,500	+21%	+$95.5K	0.01%	859
2019 Q1	$494K	Sell	7,123 -5,600	-44%	-$320K	0.01%	928
2018 Q4	$553K	Buy	12,723 +4,900	+63%	+$268K	0.01%	814
2018 Q3	$597K	Buy	7,823 +500	+7%	+$40.7K	0.01%	848
2018 Q2	$563K	Buy	7,323 +700	+11%	+$45.2K	0.01%	844
2018 Q1	$338K	Buy	6,623 +2,200	+50%	+$111K	0.01%	1148
2017 Q4	$205K	Buy	+4,423	New	+$217K	﹤0.01%	1241

Other funds holding RARE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Xact Kapitalforvaltning's RARE Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Ultragenyx Pharmaceutical (RARE) position steady in Q1 2020 at 8,623 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #881.

Xact Kapitalforvaltning first reported a position in RARE in Q4 2017 and has held it in 10 quarters since. The position peaked at $597K in Q3 2018. 174 funds tracked by Wall St. Rank hold RARE as of Q1 2020.

Xact Kapitalforvaltning held 8,623 shares of Ultragenyx Pharmaceutical worth $383K as of Q1 2020.
Xact Kapitalforvaltning left its Ultragenyx Pharmaceutical share count unchanged in Q1 2020.
Ultragenyx Pharmaceutical made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #881 holding.
Xact Kapitalforvaltning first reported a position in Ultragenyx Pharmaceutical in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Ultragenyx Pharmaceutical position peaked at $597K in Q3 2018.
174 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.